Podcast

Daily News Recap - May 18, 2017

05/18/2017

Read the news briefs here:

1. FDA Expands Approval of Cystic Fibrosis Drug

2. Experimental Cholesterol Drug Found Ineffective

3. Leukemia Drug Has Potential to Treat Asthma

4. Could Oral Iron Supplementation Improve Exercise Capacity in HF Patients?

5. Does Age of Hypertension Onset Affect Cardiovascular Outcomes?

Related Content

Allergy & Immunology
Allergy & Immunology
David A. Hill, MD, PhD, on The Atopic March: Is There a Fifth Member?
03/13/2019
David A. Hill, MD, PhD, of the Children's Hospital of Philadelphia, discusses common misunderstandings among allergists regarding the atopic march, as well as new research suggesting that there may be yet...
03/13/2019
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Brian King, PhD, MPH, on Rehospitalization, Death Rates Among Patients With EVALI
06/25/2021
In this podcast, Brian King, PhD, MPH, discusses his team's latest research on the prevalence of and risk factors for rehospitalization and death after discharge of patients with e-cigarette and...
06/25/2021
Endocrine Disorders
Endocrine Disorders
Jeffrey Levine, MD: PCOS, CVD Risk, and the Role of Primary Care
09/26/2019
In this podcast, Dr Levine discusses the diagnosis of PCOS in the primary care setting, addressing associated cardiovascular risks, and the 5 main goals of treatment.
09/26/2019
Neurology
Neurology
Rebecca Gottesman, MD, on the Effect of Midlife Vascular Disease on Dementia Later in Life
04/19/2017
Rebecca Gottesman, MD, explains the risk factors in midlife (such as obesity and high cholesterol) that may indicate an increased risk of cognitive decline later in life.
04/19/2017
Cardiology
Cardiology
William R. Hiatt, MD, on the Practice-Guiding Results of a VOYAGER-PAD Subgroup Analysis
05/05/2020
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
05/05/2020